Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1321)	1/28/2000 2:08:00 PM
From: Mark Bartlett	Respond to of 2344

Jibacoa, <<When they do and complete successfully a Phase II. It will be some time and a lot more money required before they could consider starting a phase III trial.>> I agree -- while they look interesting, they have many regulatory hurdles in their future ..... that being said, I suspect there will be a lot of volatility, so there will be opportunities to hedge your position. As far as Biomira goes, they look nicely poised -- but for near-term price appreciation, IMHO you are going to kick yourself in the butt if you do not check out Dimethaid Research Inc. (DMX) on the TSE (Nasdaq listing this year). Not intending to spam the thread, but one good turn deserves another. 'Nough said ... best to all, MB